What is a normal ejection fraction and what ejection fraction values are considered pathologic?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Normal and Pathologic Ejection Fraction Values

A normal ejection fraction is ≥50%, and an EF ≤40% is definitively pathologic, defining heart failure with reduced ejection fraction (HFrEF). 1

Classification Framework

The 2022 AHA/ACC/HFSA guidelines provide the authoritative classification system for EF 1:

Normal EF: ≥50%

  • This represents preserved systolic function
  • Patients with heart failure symptoms and EF ≥50% are classified as HFpEF (heart failure with preserved ejection fraction)

Mildly Reduced EF (HFmrEF): 41-49%

  • This intermediate range represents a dynamic state
  • Patients typically are either improving from HFrEF or deteriorating toward it
  • One measurement is insufficient - you must track the trajectory over time
  • These patients require additional objective evidence of cardiac dysfunction (elevated natriuretic peptides, evidence of increased LV filling pressures) to confirm heart failure diagnosis

Reduced EF (HFrEF): ≤40%

  • This is definitively pathologic
  • Most randomized controlled trials demonstrating survival benefit enrolled patients with EF ≤35% or ≤40%
  • This threshold triggers guideline-directed medical therapy with proven mortality benefit

Refined Understanding from Population Data

Recent meta-analysis data provides more granular normal ranges 2:

  • Lower limit of normal: approximately 52% for men and 53% for women
  • Mean normal EF: 62.8% overall (61.9% men, 63.7% women)
  • Critical threshold: An EF <50% has <5% probability of being within normal range across all demographic groups
  • Asian populations show 2-3 percentage points higher values

Clinical implication: While guidelines use ≥50% as the HFpEF threshold, population data suggests that EF values of 50-52% in men or 50-53% in women warrant close monitoring, as they fall at the extreme lower boundary of normal.

Prognostic Significance

The "low-normal" range (50-55%) carries clinical importance 3:

  • Asymptomatic individuals with EF 50-54% have 3.6-fold increased risk of developing heart failure over 10 years compared to those with EF ≥55%
  • This risk is lower than those with EF <50% (9.5-fold increased risk) but still clinically significant
  • However, low-normal EF does not increase mortality risk in asymptomatic patients

Common Pitfalls to Avoid

  1. Don't rely on single measurements in the 41-49% range - serial assessments are essential to determine trajectory
  2. Don't dismiss EF of 50-54% as completely normal - these patients need cardiovascular risk factor optimization and monitoring
  3. Don't assume normal EF excludes heart failure - HFpEF represents at least 50% of heart failure cases and is increasing in prevalence 1
  4. Don't forget that EF can vary by measurement technique - ensure consistency in follow-up assessments

Sex and Age Considerations

  • Women have slightly higher normal EF values (approximately 2% higher than men) 2
  • Age does not significantly affect normal EF ranges in most studies
  • Women with heart failure are more likely to have preserved EF than men 4

Related Questions

Is an ejection fraction of 50-55% considered within the normal range?
What is considered a normal left ventricular ejection fraction (LVEF)?
What is ejection fraction, what values are considered normal or abnormal, and how should reduced ejection fraction be managed?
Is a high ejection fraction on an echocardiogram concerning in an asymptomatic adult?
In an 84-year-old woman, is a decline in left ventricular ejection fraction from 62% to 58% over two years clinically significant?
How can I prevent my body from adapting to my current resistance‑training and high‑intensity interval training (HIIT) routine?
Do haloperidol 5 mg PO BID, valproic acid (Depakote DR) 1000 mg PO BID, trazodone 200 mg PO QHS, lithium 900 mg PO QHS, clonazepam 0.5 mg PO TID, and paliperidone (Invega) 234 mg LAI cause urinary incontinence?
Can haloperidol precipitate or worsen psychosis, particularly at high doses, rapid administration, or in elderly patients with dementia?
What is the recommended protocol for transitioning a patient from Leqvio (inclisiran) to Repatha (evolocumab)?
Can haloperidol (Haldol) cause psychosis in adolescents?
What is the recommended treatment plan for a stable 21-year-old male who developed an intra‑abdominal abscess after laparoscopic appendectomy with a perforated tip, presenting with leukocytosis and low‑grade fever, after percutaneous drain placement, with cultures showing gram‑positive cocci and gram‑positive bacilli, and who is currently on ceftriaxone and metronidazole?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.